Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
3.660
+0.430 (13.31%)
At close: Oct 15, 2025, 4:00 PM EDT
3.780
+0.120 (3.28%)
After-hours: Oct 15, 2025, 7:58 PM EDT
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $226.99 million as of October 15, 2025. Its market cap has increased by 5.52% in one year.
Market Cap
226.99M
Enterprise Value
158.43M
1-Year Change
5.52%
Ranking
Category
Stock Price
$3.66
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $226.99M, a decrease of -56.66%. That is a compound annual growth rate of -18.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 200.32M | 115.94% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |